Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on December 19, 2002; DOI 10.1182/blood-2002-05-1515.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-05-1515v1
101/8/3229    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, J. J.
Right arrow Articles by Kersey, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, J. J.
Right arrow Articles by Kersey, J. H.
Related Collections
Right arrow Hematopoiesis and Stem Cells
Right arrow Neoplasia
Right arrow Transplantation
Right arrow Oncogenes and Tumor Suppressors
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 15 April 2003, Vol. 101, No. 8, pp. 3229-3235

NEOPLASIA

Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia

Jennifer J. Johnson, Weili Chen, Wendy Hudson, Qing Yao, Marnie Taylor, Terence H. Rabbitts, and John H. Kersey

From the University of Minnesota Cancer Center, Minneapolis; and Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom.

The steps to leukemia following an in utero fusion of MLL (HRX, ALL-1) to a partner gene in humans are not known. Introduction of the Mll-AF9 fusion gene into embryonic stem cells results in leukemia in mice with cell-type specificity similar to humans. In this study we used myeloid colony assays, immunophenotyping, and transplantation to evaluate myelopoiesis in Mll-AF9 mice. Colony assays demonstrated that both prenatal and postnatal Mll-AF9 tissues have significantly increased numbers of CD11b+/CD117+/Gr-1+/- myeloid cells, often in compact clusters. The self-renewal capacity of prenatal myeloid progenitors was found to decrease following serial replating of colony-forming cells. In contrast, early postnatal myeloid progenitors increased following replating; however, the enhanced self-renewal of early postnatal myeloid progenitor cells was limited and did not result in long-term cell lines or leukemia in vivo. Unlimited replating, long-term CD11b/Gr-1+ myeloid cell lines, and the ability to produce early leukemia in vivo in transplantation experiments, were found only in mice with overt leukemia. Prenatal Mll-AF9 tissues had reduced total (mature and progenitor) CD11b/Gr-1+ cells compared with wild-type tissues. Colony replating, immunophenotyping, and cytochemistry suggest that any perturbation of cellular differentiation from the prenatal stage onward is partial and largely reversible. We describe a novel informative in vitro and in vivo model system that permits study of the stages in the pathogenesis of Mll fusion gene leukemia, beginning in prenatal myeloid cells, progressing to a second stage in the postnatal period and, finally, resulting in overt leukemia in adult animals.

© 2003 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
S. J. Horton, V. Walf-Vorderwulbecke, S. J. Chatters, N. J. Sebire, J. de Boer, and O. Williams
Acute myeloid leukemia induced by MLL-ENL is cured by oncogene ablation despite acquisition of complex genetic abnormalities
Blood, May 14, 2009; 113(20): 4922 - 4929.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. Kumar, Q. Li, W. A. Hudson, W. Chen, T. Sam, Q. Yao, E. A. Lund, B. Wu, B. J. Kowal, and J. H. Kersey
A role for MEIS1 in MLL-fusion gene leukemia
Blood, February 19, 2009; 113(8): 1756 - 1758.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W.-I. Kim, I. Matise, M. D. Diers, and D. A. Largaespada
RAS oncogene suppression induces apoptosis followed by more differentiated and less myelosuppressive disease upon relapse of acute myeloid leukemia
Blood, January 29, 2009; 113(5): 1086 - 1096.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. W. Robinson, N.-K. V. Cheung, C. P. Kolaris, S. C. Jhanwar, J. K. Choi, N. Osheroff, and C. A. Felix
Prospective tracing of MLL-FRYL clone with low MEIS1 expression from emergence during neuroblastoma treatment to diagnosis of myelodysplastic syndrome
Blood, April 1, 2008; 111(7): 3802 - 3812.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Chen, Q. Li, W. A. Hudson, A. Kumar, N. Kirchhof, and J. H. Kersey
A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy
Blood, July 15, 2006; 108(2): 669 - 677.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. R. Kumar, W. A. Hudson, W. Chen, R. Nishiuchi, Q. Yao, and J. H. Kersey
Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia
Blood, March 1, 2004; 103(5): 1823 - 1828.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020